✦ LIBER ✦

Safety and Immunogenicity of a Recombinant Borrelia burgdorferi Outer Surface Protein A Vaccine Against Lyme Disease in Healthy Children and Adolescents: A Randomized Controlled Trial

✍ Scribed by Sikand, V. K.; Halsey, N.; Krause, P. J.; Sood, S. K.; Geller, R.; Van Hoecke, C.; Buscarino, C.; Parenti, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of a recombinant Borrelia

✍ Henry M. Feder Jr; Jeri Beran; Christian Van Hoecke; Betsy Abraham; Norbert De C 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Safety and immunogenicity of recombinant

✍ Robert Edelman; Kathleen Palmer; Karin G Russ; Helen P Secrest; Jo Anna L. Becke 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Safety and immunogenicity profile of a r

✍ Robert T. Schoen; Vijay K. Sikand; Michael C. Caldwell; C. Van Hoecke; Marc Gill 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 699 KB

Safety and immunogenicity of two subunit

✍ Feng Cai Zhu; Weizhong Zhou; Hongxing Pan; Lily Lu; Lisya Gerez; Jos Nauta; Kati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 181 KB

An open-label, nonrandomized, single-cen

✍ Robert T Schoen; Terry Deshefy-Longhi; Christian Van-Hoecke; Charles Buscarino; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 816 KB

Safety, immunogenicity, and tolerability

✍ Richmond, Peter C; Marshall, Helen S; Nissen, Michael D; Jiang, Qin; Jansen, Kat 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 293 KB